癌肿消治疗胃癌术后气滞血瘀证的临床观察

发布时间：2018-08-02 11:31

【摘要】：目的:本文通过观察癌肿消对胃癌术后气滞血瘀证患者的临床症状、生活质量、体重等近期疗效指标的改变,评价癌肿消的疗效,为中医药治疗胃癌提供新思路。方法:选择符合纳入标准的胃癌术后患者64例,用随机数字表法分为两组,治疗组32例,对照组32例,对照组采用胃复春治疗,治疗组采用癌肿消,分别对两组病人临床症候疗效、生活质量变化、体重变化等方面进行对比研究。结果:(1)在中医证候疗效方面,治疗组的总有效率高于对照组,差异有统计学意义(P0.05);治疗组在改善胃脘疼痛、食后腹胀、恶心呕吐、反酸嗳气等症状方面优于对照组(P0.05),在缓解腹部压痛、改善口唇面色晦暗及舌象瘀血等体征方面优于对照组(P0.05)。(2)治疗组和对照组均能提高患者的生活质量评分,两组治疗前后均有统计学差异(P0.05);与对照组比较,治疗组的总有效率明显高于对照组,差异有统计学意义(P0.05)。(3)治疗组治疗后可稳定或增加患者的体重,治疗前后有统计学差异(P0.05),对照组治疗前后在稳定或增加体重方面无统计学差异(P0.05);与对照组比较,治疗组的总有效率明显高于对照组,差异有统计学意义(P0.05)。结论:癌肿消能有效改善胃癌术后患者气滞血瘀证的临床症状,稳定或增加体重,提高生活质量。
[Abstract]:Objective: to evaluate the effect of Qiangzhongxiao on the treatment of gastric cancer by observing the changes of clinical symptoms, quality of life and body weight in patients with qi stagnation and blood stasis syndrome after operation of gastric cancer, so as to provide a new idea for the treatment of gastric cancer with traditional Chinese medicine. Methods: 64 patients with gastric cancer were randomly divided into two groups: treatment group (n = 32), control group (n = 32) and control group (n = 32). The clinical symptoms, quality of life and weight were compared between the two groups. Results: (1) the total effective rate of the treatment group was higher than that of the control group (P0.05); the treatment group in improving epigastric pain, abdominal distension after eating, nausea and vomiting, The symptoms of acid regurgitation and belching were better than that of the control group (P0.05), and the symptoms of relieving abdominal tenderness, improving lip color and blood stasis were better than those of the control group (P0.05). (2), both the treatment group and the control group could improve the quality of life score of the patients. Compared with the control group, the total effective rate of the treatment group was significantly higher than that of the control group, the difference was statistically significant (P0.05). (3) the treatment group could stabilize or increase the weight of the patients after treatment, and compared with the control group, the total effective rate of the treatment group was significantly higher than that of the control group (P0.05). Before and after treatment there was statistical difference (P0.05), the control group before and after treatment in stable or weight gain no statistical difference (P0.05); compared with the control group, the total effective rate of the treatment group was significantly higher than the control group, the difference was statistically significant (P0.05). Conclusion: Yiyongxiao can effectively improve the clinical symptoms of qi stagnation and blood stasis syndrome, stabilize or increase body weight, and improve the quality of life in patients with gastric cancer after operation.
【学位授予单位】：广西中医药大学
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：R273

【参考文献】